<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03312166</url>
  </required_header>
  <id_info>
    <org_study_id>API/2016/75</org_study_id>
    <nct_id>NCT03312166</nct_id>
  </id_info>
  <brief_title>Compressive Device to Prevent Keloïd Scars Recurrence [SCARWARS]</brief_title>
  <acronym>SCARWARS</acronym>
  <official_title>First Study Evaluating Efficiency and Safety of a Compressive Device to Prevent Keloid Scars Recurrence After Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire de Besancon</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire de Besancon</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      SCARWARS study deals with the first on-human evaluation of a compressive device dedicated to
      the prevention of keloïd scars recurrence after surgery. The tested device is made with
      clinical grade silicon. SCARWARS is a monocentric study. 27 patients will be include and
      follow during one year. The primary outcome of this study is the number of keloid recurrence
      after treatment.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 3, 2017</start_date>
  <completion_date type="Anticipated">October 2020</completion_date>
  <primary_completion_date type="Anticipated">October 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Recurrence of keloid scar</measure>
    <time_frame>12 month</time_frame>
    <description>Recurrence will be assessed during each visit by surgeon</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">27</enrollment>
  <condition>Keloid</condition>
  <arm_group>
    <arm_group_label>Compression device</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Compression device</intervention_name>
    <description>interventions on patient are :
surgical excision of ear lobe keloid
application of compression device on sutured skin</description>
    <arm_group_label>Compression device</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient over 18 yo;

          -  Patient with aer lobe keloid;

          -  Patient with an indication of reconstructive surgery;

          -  Signature of informed consent from the patient;

          -  Indication that the subject has understood the purpose and procedures required by the
             study and agrees to participate in the study and comply with the requirements and
             limitations inherent in this study;

          -  Patient with French social insurance.

        Exclusion Criteria:

          -  Patient with cutaneous dermatosis or other skin pathology able to interfere with
             evaluated parameter (recurrence and healing quality);

          -  Patient with know nickel allergy;

          -  Patient with know silicon allergy;

          -  Pregnant women;

          -  Legal incapacity or limited legal capacity;

          -  Patient unlikely to cooperate in the study and / or low cooperation anticipated by the
             investigator;

          -  Patient without health insurance;

          -  The patient is in the period of exclusion of another study.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Brice Chatelain, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centre Hospitalier Universitaire de Besançon</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Gwenael Rolin, PhD</last_name>
    <phone>0033 3 81 21 91 64</phone>
    <email>grolin@chu-besancon.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Lihoreau Thomas, Ing</last_name>
    <email>tlihoreau@chu-besancon.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>CHU de Besançon</name>
      <address>
        <city>Besançon</city>
        <zip>25000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thomas Lihoreau, Ing</last_name>
      <email>tlihoreau@chu-besancon.fr</email>
    </contact>
    <contact_backup>
      <last_name>Gwenaël Rolin, PhD</last_name>
      <email>grolin@chu-besancon.fr</email>
    </contact_backup>
    <investigator>
      <last_name>Brice Chatelain, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>October 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 12, 2017</study_first_submitted>
  <study_first_submitted_qc>October 12, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">October 17, 2017</study_first_posted>
  <last_update_submitted>October 18, 2017</last_update_submitted>
  <last_update_submitted_qc>October 18, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">October 19, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>ear lobe</keyword>
  <keyword>compression</keyword>
  <keyword>medical device</keyword>
  <keyword>recurrence</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Recurrence</mesh_term>
    <mesh_term>Keloid</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

